• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 51 Show All Page 1 of 2
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  1162
Fungal oil (≥38% arachidonic acid (ARA)) from Mortierella alpina FJRK-MA01 Feb 8, 2024 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (236 kB)
  1156
Algal oil (≥35% docosahexaenoic acid) from Schizochytrium sp. FJRK-SCH3 Feb 8, 2024 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (204 kB)
  1148
D-psicose Pending
  1145
β-lactoglobulin produced by Aspergillus oryzae strain Ao_st0002 Pending
  1136
Dry whole goat milk Oct 31, 2023 FDA has no questions (in PDF) (267 kB)
  1132
Hydrolyzed poultry protein Pending
  1077
Oat polar lipid extract Pending
  1069
Corn protein Pending
  1058
Polyvinyl alcohol Jun 9, 2023 FDA has no questions (in PDF) (283 kB)
  1056
β-lactoglobulin produced by Komagataella phaffii strain yRMK-66 Feb 15, 2023 FDA Has No Questions (in PDF) (291 kB)
  1034
2'-fucosyllactose Oct 21, 2022 FDA has no questions (in PDF) (258 kB)
  993
L-carnitine-L-tartrate Oct 18, 2021 FDA has no questions (in PDF) (149 kB)
  960
Hypromellose acetate succinate Dec 21, 2021 FDA has no questions (126 kB)
  954
Fibrillated cellulose Jun 10, 2021 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (111 kB)
  941
Oat polar lipid extract Jun 11, 2021 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (124 kB)
  930
Silk fibroin derived from Bombyx mori cocoons May 25, 2021 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (128 kB)
  910
Thaumatin II Sep 9, 2020 FDA has no questions (in PDF) (541 kB)
  894
White mulberry leaf extract Nov 19, 2020 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (201 kB)
  876
Hydroxytyrosol Jan 21, 2020 FDA has no questions (in PDF) (88 kB)
  874
Corn protein Apr 29, 2020 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (44 kB)
  851
Pea protein Apr 15, 2020 FDA has no questions (in PDF) (601 kB)
  845
Lactobacillus rhamnosus LGG Oct 30, 2019 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (121 kB)
  791
Urolithin A Dec 20, 2018 FDA has no questions (in PDF) (145 kB)
  772
Palmitoylated green tea catechins Dec 13, 2018 FDA has no questions (in PDF) (63 kB)
  738
Thaumatin Apr 18, 2018 FDA has no questions (in PDF) (77 kB)
  710
Basic methacrylate copolymer Dec 8, 2017 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (50 kB)
  675
Xylanase enzyme preparation produced by Trichoderma reesei carrying a xylanase gene from Talaromyces leycettanus Apr 6, 2017 FDA has no questions (in PDF) (76 kB)
  654
Cocoa butter substitute manufactured using palm oil stearin and stearic acid Dec 19, 2016 FDA has no questions
  644
Non-fat dry goat milk and goat whey protein Oct 11, 2016 FDA has no questions
  633
Concentrated milk protein with a ≥ 60:40 whey:casein ratio Sep 21, 2016 FDA has no questions
  583
Esterified propoxylated glycerol Nov 12, 2015 FDA has no questions
  575
Oat protein Sep 18, 2015 FDA has no questions
  554
Synthetic amorphous silica May 14, 2015 FDA has no questions
  544
β-glucans from oat bran May 5, 2015 FDA has no questions
  437
Beta-glucans from oat bran Jan 27, 2013 FDA has no questions
  427
Corn hull fiber Sep 12, 2012 FDA has no questions
  400
D-psicose Jun 18, 2012 FDA has no questions
  366
Oat hull fiber Apr 6, 2011 At the notifier's request, FDA ceased to evaluate this notice
  342
Oat hull fiber Dec 23, 2010 FDA has no questions
  340
Theobromine Nov 10, 2010 At the notifier's request, FDA ceased to evaluate this notice
  314
Pork protein Aug 11, 2010 FDA has no questions
  313
Beef protein Aug 11, 2010 FDA has no questions
  312
Synthetic dihydrocapsiate Jun 6, 2010 FDA has no questions
  261
Oat hull fiber Feb 3, 2009 FDA has no questions Oct 14, 2016
  249
Synthetic dihydrocapsiate Mar 9, 2009 FDA has no questions
  219
Ammonium phosphatide Jun 29, 2007 FDA has no questions
  147
Extracted "seafood species" protein Aug 26, 2004 FDA has no questions Nov 21, 2008
Nov 14, 2008
  141
Polyvinyl alcohol Apr 28, 2004 FDA has no questions
  107
Polydextrose Oct 17, 2002 At the notifier's request, FDA ceased to evaluate this notice
  50
Bohenin Aug 31, 2000 FDA has no questions

Show All 

jump to page of 2 


GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-